Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PANITUMUMAB for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 43 adverse event reports in the FDA FAERS database where PANITUMUMAB was used for Off label use.

Most Reported Side Effects for PANITUMUMAB

Side Effect Reports % Deaths Hosp.
Rash 1,392 12.8% 121 291
Diarrhoea 1,123 10.3% 146 413
Death 767 7.1% 767 127
Dermatitis acneiform 758 7.0% 71 167
Neutropenia 757 7.0% 84 112
Skin toxicity 728 6.7% 38 59
Neuropathy peripheral 613 5.6% 45 67
Hypomagnesaemia 611 5.6% 63 117
Nausea 608 5.6% 88 174
Disease progression 600 5.5% 155 67
Colorectal cancer metastatic 583 5.4% 182 87
Off label use 563 5.2% 103 98
Fatigue 505 4.6% 67 131
Thrombocytopenia 480 4.4% 61 119
Paronychia 443 4.1% 38 107

Other Indications for PANITUMUMAB

Colorectal cancer metastatic (3,420) Product used for unknown indication (1,810) Colon cancer (1,726) Colorectal cancer (878) Adenocarcinoma of colon (610) Colon cancer metastatic (398) Metastases to liver (391) Rectal cancer (374) Rectal adenocarcinoma (195) Rectal cancer metastatic (145)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

PANITUMUMAB Full Profile All Off label use Drugs PANITUMUMAB Demographics PANITUMUMAB Timeline